ArticleScientific reports2025

Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomes.

Brandon Havranek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.